Effectiveness of chatbots on COVID vaccine confidence and acceptance in Thailand, Hong Kong, and Singapore

Kristi Yoonsup Lee, Saudamini Vishwanath Dabak, Vivian Hanxiao Kong, Minah Park, Shirley L L Kwok, Madison Silzle, Chayapat Rachatan, Alex Cook, Aly Passanante, Ed Pertwee, Zhengdong Wu, Javier A Elkin, Heidi J Larson, Eric H Y Lau, Kathy Leung, Joseph T Wu, Leesa Lin, Kristi Yoonsup Lee, Saudamini Vishwanath Dabak, Vivian Hanxiao Kong, Minah Park, Shirley L L Kwok, Madison Silzle, Chayapat Rachatan, Alex Cook, Aly Passanante, Ed Pertwee, Zhengdong Wu, Javier A Elkin, Heidi J Larson, Eric H Y Lau, Kathy Leung, Joseph T Wu, Leesa Lin

Abstract

Chatbots have become an increasingly popular tool in the field of health services and communications. Despite chatbots' significance amid the COVID-19 pandemic, few studies have performed a rigorous evaluation of the effectiveness of chatbots in improving vaccine confidence and acceptance. In Thailand, Hong Kong, and Singapore, from February 11th to June 30th, 2022, we conducted multisite randomised controlled trials (RCT) on 2,045 adult guardians of children and seniors who were unvaccinated or had delayed vaccinations. After a week of using COVID-19 vaccine chatbots, the differences in vaccine confidence and acceptance were compared between the intervention and control groups. Compared to non-users, fewer chatbot users reported decreased confidence in vaccine effectiveness in the Thailand child group [Intervention: 4.3 % vs. Control: 17%, P = 0.023]. However, more chatbot users reported decreased vaccine acceptance [26% vs. 12%, P = 0.028] in Hong Kong child group and decreased vaccine confidence in safety [29% vs. 10%, P = 0.041] in Singapore child group. There was no statistically significant change in vaccine confidence or acceptance in the Hong Kong senior group. Employing the RE-AIM framework, process evaluation indicated strong acceptance and implementation support for vaccine chatbots from stakeholders, with high levels of sustainability and scalability. This multisite, parallel RCT study on vaccine chatbots found mixed success in improving vaccine confidence and acceptance among unvaccinated Asian subpopulations. Further studies that link chatbot usage and real-world vaccine uptake are needed to augment evidence for employing vaccine chatbots to advance vaccine confidence and acceptance.

Conflict of interest statement

There are no competing interests for any author. JAE’s institutional affiliation is provided for identification purpose only and does not constitute institutional endorsement. Any views and opinions expressed are personal and belong solely to the individual and do not represent any people, institutions, or organizations that the individual may be associated with in a personal or professional capacity unless explicitly stated.

© 2023. The Author(s).

Figures

Fig. 1. Flow diagram of the randomised…
Fig. 1. Flow diagram of the randomised controlled trial in Thailand, Hong Kong, and Singapore.
Flowchart presenting the number of participants assessed, enrolled, randomized, lost to follow-up, and analysed in each child group and senior group.
Fig. 2. Associations between vaccine confidence and…
Fig. 2. Associations between vaccine confidence and acceptance and sociodemographic factors, misinformation, risk perception, and chatbot use in Thailand child group.
A proportional odds logistic regression model adjusted for respondent’s sex, age, and employment status. Reference groups for a: respondent’s ethnicity: Thai (number of participants:125, percentage of the total participants: 93%); respondent’s education level: below college level (66, 49%); respondent is a healthcare worker?: yes (17, 13%); financial situation: low (29, 22%); geographical location: urban (51, 38%); child’s gender: female (64, 48%); chatbot use: no (65, 49%). *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001. b Refers to the association between pre-intervention misinformation awareness and risk perception with primary outcomes, for example, higher misinformation awareness (“COVID-19 vaccines cause death”) in the pre-intervention questionnaire is positively associated with increase in vaccine confidence (“Vaccines are effective against all variants”) (OR = 1.41 (95% CI: 1.07–1.84)).
Fig. 3. Associations between vaccine confidence and…
Fig. 3. Associations between vaccine confidence and acceptance and sociodemographic factors, misinformation, risk perception, and chatbot use in Thailand senior group.
A proportional odds logistic regression model adjusted for respondent’s employment status. Reference groups for a: respondent’s ethnicity: Thai (number of participants: 119, percentage of the total participants: 90%); respondent’s sex: female (74, 56%); respondent’s age: 35 and under (84, 64%); respondent’s education level: below college level (66, 50%); respondent is a healthcare worker?: yes (24, 18%); financial situation: low (24, 18%); geographical location: urban (53, 40%); senior’s gender: female (76, 58%); senior’s age: 60–80 (105, 80%); chatbot use: no (73, 55%). *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001. b Refers to the association between pre-intervention misinformation awareness and risk perception with primary outcomes, for example, higher misinformation awareness (“COVID-19 vaccines cause death”) in the pre-intervention questionnaire is positively associated with increase in vaccine confidence (“Vaccines are effective against all variants”) (OR = 1.68 (95% CI: 1.13–2.49)).
Fig. 4. Associations between vaccine confidence and…
Fig. 4. Associations between vaccine confidence and acceptance and sociodemographic factors, misinformation, risk perception, and chatbot use in Hong Kong child group.
A proportional odds logistic regression model adjusted for respondent’s sex, age, and employment status. Reference groups for a: respondent’s ethnicity: Chinese (number of participants: 87, percentage of the total participants: 44%; respondent’s education level: below college level (99, 50%); respondent is a healthcare worker?: yes (10, 5.0%); family income: under 30 K HKD (127, 64%); child’s gender: female (86, 43%); chatbot use: no (109, 54.8%)). *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001. b Refers to the association between pre-intervention misinformation awareness and risk perception with primary outcomes, for example, higher misinformation awareness (“COVID-19 vaccines cause infection”) in the pre-intervention questionnaire is positively associated with increase in vaccine confidence (“Vaccines are important”) (OR = 2.24 (95% CI: 1.39–3.62)).
Fig. 5. Associations between vaccine confidence and…
Fig. 5. Associations between vaccine confidence and acceptance and sociodemographic factors, misinformation, risk perception, and chatbot use in Hong Kong senior group.
A proportional odds logistic regression model adjusted for respondent’s employment status. Reference groups for a: respondent’s ethnicity: Chinese (number of participants: 113, percentage of the total participants: 60%); respondent’s sex: female (116, 62%); respondent’s age: 35 and under (78, 42%); respondent’s education level: below college level (86, 46%); respondent is a healthcare worker?: yes (11, 5.9%); family income: under 30 K HKD (113, 60%); senior’s gender: female (107, 57%); senior’s age: 60 to 80 (138, 73%); chatbot use: no (106, 56%). *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001. b Refers to the association between pre-intervention misinformation awareness and risk perception with primary outcomes, for example, higher misinformation awareness (“COVID-19 vaccines cause death”) in the pre-intervention questionnaire is positively associated with increase in vaccine confidence (“Vaccines are effective”) (OR = 1.84 (95% CI: 1.28–2.64)).
Fig. 6. Associations between vaccine confidence and…
Fig. 6. Associations between vaccine confidence and acceptance and sociodemographic factors, misinformation, risk perception, and chatbot use in Singapore child group.
A proportional odds logistic regression model adjusted for respondent’s sex and employment status, and housing type. Reference groups for a: respondent’s ethnicity: Chinese (number of participants: 44, percentage of the total participants: 46%); respondent’s age: 35 and under (40, 42%); respondent’s education level: below college level (49, 52%); is respondent a healthcare worker?: yes (15, 16%); child’s gender: female (33, 35%); chatbot use: no (50, 52.6%). *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001. b Refers to the association between pre-intervention misinformation awareness and risk perception with primary outcomes, for example, higher misinformation awareness (“COVID-19 vaccines cause genetic change”) in the pre-intervention questionnaire is positively associated with increase in vaccine confidence (“Vaccines are important”) (OR = 7.28 (95% CI: 2.35–22.54)).

References

    1. WHO. WHO Coronavirus (COVID-19) Dashboard. (2022).
    1. Worldometers. COVID-19 Coronavirus Pandemic. (2022).
    1. Polack FP, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577.
    1. Rubin R. COVID-19 vaccines vs variants—determining how much immunity is enough. JAMA. 2021;325:1241–1243. doi: 10.1001/jama.2021.3370.
    1. WHO. Ten Threats to Global Health in 2019. (2020).
    1. World Health Organization. L’Organisation mondiale de la Santé. Wkly Epidemiol. Rec. 2020;95:417–440.
    1. Ma A, Parry J. When Hong Kong’s “dynamic zero” covid-19 strategy met omicron, low vaccination rates sent deaths soaring. BMJ. 2022;377:o980. doi: 10.1136/bmj.o980.
    1. Wang, G. et al. Determinants of COVID-19 vaccination status and hesitancy among older adults in China. Nat. Med.10.1038/s41591-023-02241-7 (2023).
    1. Griva, K. et al. Evaluating rates and determinants of COVID-19 vaccine hesitancy for adults and children in the Singapore population: strengthening our community’s resilience against threats from emerging infections (SOCRATEs) cohort. Vaccines (Basel)10.3390/vaccines9121415 (2021).
    1. Kitro A, et al. Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand. Vaccine. 2021;39:7554–7561. doi: 10.1016/j.vaccine.2021.11.031.
    1. Singapore Ministry of Health. A Singapore Government Agency Website. (2022).
    1. Thailand Ministry of Public Health. Covid-19 Vaccination Dashboard Thailand. (2022).
    1. Singapore Ministry of Health. Vaccination Statistics. (2022).
    1. Census and Statistics Department. Table 1B: Population by Sex and Age. (2022).
    1. Soares, P. et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines10.3390/vaccines9030300 (2021).
    1. Sallam, M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines (Basel)10.3390/vaccines9020160 (2021).
    1. Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors. Prev. Med. 2021;150:106694. doi: 10.1016/j.ypmed.2021.106694.
    1. Harapan H, et al. Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic. Pathog. Glob. Health. 2022;116:236–243. doi: 10.1080/20477724.2021.2011580.
    1. Amiri P, Karahanna E. Chatbot use cases in the Covid-19 public health response. J. Am. Med. Inform. Assoc. 2022;29:1000–1010. doi: 10.1093/jamia/ocac014.
    1. Mueangpoon, K. et al. Self-reported COVID-19 vaccine hesitancy and willingness to pay: a cross-sectional survey in Thailand. Vaccines (Basel)10.3390/vaccines10040627 (2022).
    1. Pengid S, et al. Using Andersen’s model of health care utilization to assess factors associated with COVID-19 testing among adults in nine low-and middle-income countries: an online survey. BMC Health Serv. Res. 2022;22:265. doi: 10.1186/s12913-022-07661-8.
    1. Lau, E. Y. H., Li, J. B. & Chan, D. K. C. Intention to vaccinate young children against COVID-19: a large-scale survey of Hong Kong parents. Hum. Vaccin Immunother.10.1080/21645515.2022.2065838 (2022).
    1. Zhong Y, et al. Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore. Vaccine. 2021;39:780–785. doi: 10.1016/j.vaccine.2020.12.054.
    1. WHO. 10 Global Health Issues to Track in 2021. (2020).
    1. WHO. Managing the COVID-19 Infodemic: Promoting Healthy Behaviours and Mitigating the Harm from Misinformation and Disinformation. (2020).
    1. Gesualdo F, Bucci LM, Rizzo C, Tozzi AE. Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era. Hum. Vaccines Immunother. 2022;18:1865048. doi: 10.1080/21645515.2020.1865048.
    1. Altay, S., Hacquin, A.-S., Chevallier, C. & Mercier, H. Information delivered by a chatbot has a positive impact on COVID-19 vaccines attitudes and intentions. J. Exp. Psychol.: Appl.10.1037/xap0000400 (2021).
    1. Caldarini G, Jaf S, McGarry K. A literature survey of recent advances in chatbots. Information. 2022;13:41. doi: 10.3390/info13010041.
    1. Attwell K, Freeman M. I Immunise: an evaluation of a values-based campaign to change attitudes and beliefs. Vaccine. 2015;33:6235–6240. doi: 10.1016/j.vaccine.2015.09.092.
    1. Loft LH, Pedersen EA, Jacobsen SU, Søborg B, Bigaard J. Using Facebook to increase coverage of HPV vaccination among Danish girls: an assessment of a Danish social media campaign. Vaccine. 2020;38:4901–4908. doi: 10.1016/j.vaccine.2020.04.032.
    1. Følstad A, Skjuve M. Chatbots for customer service: user experience and motivation. In Proc. 1st International Conference on Conversational User Interfaces (ACM, Dublin, Ireland, 2019).
    1. Yuan, J. et al. Why do Chinese older adults in Hong Kong delay or refuse COVID-19 vaccination? A qualitative study based on Grounded Theory. J. Gerontol. B Psychol. Sci. Soc. Sci. 10.1093/geronb/gbac184 (2022).
    1. Zhang D, et al. Vaccine resistance and hesitancy among older adults who live alone or only with an older partner in community in the early stage of the fifth wave of COVID-19 in Hong Kong. Vaccines. 2022;10:1118. doi: 10.3390/vaccines10071118.
    1. Tan M, Straughan PT, Cheong G. Information trust and COVID-19 vaccine hesitancy amongst middle-aged and older adults in Singapore: a latent class analysis approach. Soc. Sci. Med. 2022;296:114767. doi: 10.1016/j.socscimed.2022.114767.
    1. Wu, J. et al. COVID-19 vaccine hesitancy among Chinese population: a large-scale national study. Front. Immunol.10.3389/fimmu.2021.781161 (2021).
    1. Thanapluetiwong S, Chansirikarnjana S, Sriwannopas O, Assavapokee T, Ittasakul P. Factors associated with COVID-19 vaccine hesitancy in Thai seniors. Patient Prefer Adherence. 2021;15:2389–2403. doi: 10.2147/PPA.S334757.
    1. Wang C, et al. Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: a national cross-sectional study. Vaccine. 2021;39:2833–2842. doi: 10.1016/j.vaccine.2021.04.020.
    1. Long S, et al. Changes of factors associated with vaccine hesitancy in Chinese residents: a qualitative study. Front. Pub. Health. 2022;10:929407. doi: 10.3389/fpubh.2022.929407.
    1. Kong, Y., Jiang, H., Liu, Z., Guo, Y. & Hu, D. The uptake and vaccination willingness of COVID-19 vaccine among Chinese residents: web-based online cross-sectional study. Vaccines10, 90 (2022).
    1. Li T, Qiu X, Gong X, Zhan R, Zheng X. The cross-sectional survey on COVID-19 vaccine hesitancy and it predictors among Chinese parents of 3–17 years aged children in Shenzhen City. Ann. Agric. Environ. Med. 2022;29:120–125. doi: 10.26444/aaem/146263.
    1. Crutzen R, Peters G-JY, Portugal SD, Fisser EM, Grolleman JJ. An artificially intelligent chat agent that answers adolescents’ questions related to sex, drugs, and alcohol: an exploratory study. J. Adolesc. Health. 2011;48:514–519. doi: 10.1016/j.jadohealth.2010.09.002.
    1. Moghadasi MN, Zhuang Y, & Gellban H. (eds) Robo: A Counselor Chatbot for Opioid Addicted Patients (ACM, 2020).
    1. Skorburg, J. A. & Yam, J. Is there an App for that?: Ethical issues in the digital mental health response to COVID-19. AJOB Neurosci.13, 177–190 (2021).
    1. Fadhil, A. & Gabrielli, S. (eds) Addressing challenges in promoting healthy lifestyles: the al-chatbot approach. In Proc. 11th EAI International Conference on Pervasive Computing Technologies for Healthcare (ACM, 2017).
    1. Dulin P, Mertz R, Edwards A, King D. Contrasting a mobile App with a conversational Chatbot for reducing alcohol consumption: randomized controlled pilot trial. JMIR Form. Res. 2022;6:e33037. doi: 10.2196/33037.
    1. Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine. 2009;27:3240–3244. doi: 10.1016/j.vaccine.2009.01.069.
    1. Gabarron E, Larbi D, Denecke K, Årsand E. What do we know about the use of Chatbots for public health? Stud. Health Technol. Inform. 270, 796–800 (2020).
    1. Statistics Singapore. Resident Population by Ethnic Group, Age Group and Sex Dashboard. (2021).
    1. Lee W-N, et al. Large-scale influenza vaccination promotion on a mobile app platform: a randomized controlled trial. Vaccine. 2020;38:3508–3514. doi: 10.1016/j.vaccine.2019.11.053.
    1. van Baal, S., Le, S., Fatehi, F., García, A. & Hohwy, J. Effecting behaviour change using an artificial intelligence chatbot: a pilot randomised controlled study. PsyArXiv10.31234/ (2022).
    1. Lau AY, et al. Impact of a web-based personally controlled health management system on influenza vaccination and health services utilization rates: a randomized controlled trial. J. Am. Med. Inform. Assoc. 2012;19:719–727. doi: 10.1136/amiajnl-2011-000433.
    1. Hong, Y.-J., Piao, M., Kim, J. & Lee, J.-H. Development and evaluation of a child vaccination chatbot real-time consultation messenger service during the COVID-19 pandemic. Appl. Sci.10.3390/app112412142 (2021).
    1. Kobayashi T, et al. 439. Corowa-kun: Impact of a COVID-19 vaccine information Chatbot on vaccine hesitancy, Japan 2021. Open Forum Infect. Dis. 2021;8:S321–S322. doi: 10.1093/ofid/ofab466.638.
    1. Pandit, J. A., Radin, J. M., Quer, G. & Topol, E. J. Smartphone apps in the COVID-19 pandemic. Nat. Biotechnol.10.1038/s41587-022-01350-x (2022).
    1. Pluviano S, Watt C, Della Sala S. Misinformation lingers in memory: Failure of three pro-vaccination strategies. PLoS One. 2017;12:e0181640. doi: 10.1371/journal.pone.0181640.
    1. Ecker UKH, Lewandowsky S, Chadwick M. Can corrections spread misinformation to new audiences? Testing for the elusive familiarity backfire effect. Cogn. Res. Princ. Implic. 2020;5:41. doi: 10.1186/s41235-020-00241-6.
    1. Følstad A, et al. Future directions for chatbot research: an interdisciplinary research agenda. Computing. 2021;103:2915–2942. doi: 10.1007/s00607-021-01016-7.
    1. Korda H, Itani Z. Harnessing social media for health promotion and behavior change. Health Promot. Pract. 2013;14:15–23. doi: 10.1177/1524839911405850.
    1. Pereira da Veiga CR, Semprebon E, da Silva JL, Lins Ferreira V, Pereira da Veiga C. Facebook HPV vaccine campaign: insights from Brazil. Hum. Vaccine Immunother. 2020;16:1824–1834. doi: 10.1080/21645515.2019.1698244.
    1. Bono, S. A. et al. Adults’ acceptance of COVID-19 vaccine for children in selected lower- and middle-income countries. Vaccines (Basel)10.3390/vaccines10010011 (2021).
    1. Horiuchi S, et al. Factors of parental COVID-19 vaccine hesitancy: a cross sectional study in Japan. PLoS One. 2021;16:e0261121. doi: 10.1371/journal.pone.0261121.
    1. Wan X, et al. Willingness and influential factors of parents of 3–6-year-old children to vaccinate their children with the COVID-19 vaccine in China. Hum. Vaccines Immunother. 2021;17:3969–3974. doi: 10.1080/21645515.2021.1955606.
    1. McDonald RP, Ho MH. Principles and practice in reporting structural equation analyses. Psychol. Methods. 2002;7:64–82. doi: 10.1037/1082-989X.7.1.64.
    1. Sun J. Assessing goodness of fit in confirmatory factor analysis. Meas. Eval. Couns. Dev. 2005;37:240–256. doi: 10.1080/07481756.2005.11909764.
    1. Rosseel Y. lavaan: An R package for structural equation modeling. J. Stat. Softw. 2012;48:1–36. doi: 10.18637/jss.v048.i02.
    1. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am. J. Public Health. 1999;89:1322–1327. doi: 10.2105/AJPH.89.9.1322.
    1. Gaglio B, Shoup JA, Glasgow RE. The RE-AIM framework: a systematic review of use over time. Ame. J. Pub. Health. 2013;103:e38–e46. doi: 10.2105/AJPH.2013.301299.
    1. Tran V-T, Sidorkiewicz S, Péan C, Ravaud P. Impact of an interactive web tool on patients’ intention to receive COVID-19 vaccination: a before-and-after impact study among patients with chronic conditions in France. BMC Med. Inform. Decis. Mak. 2021;21:228. doi: 10.1186/s12911-021-01594-8.
    1. Education Bureau. Arrangements of Resumption of Face-to-Face Classes after Schools’ Easter Holidays. (2022).
    1. Premise. Data for Every Decision™. (2022).
    1. Bangkok Post. Ministry of Public Health and Thai Health Promotion Foundation Partner with Facebook. (2021).
    1. de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. The Lancet. 2020;396:898–908. doi: 10.1016/S0140-6736(20)31558-0.
    1. Yadete, T. et al. Assessing acceptability of COVID-19 vaccine booster dose among adult americans: a cross-sectional study. Vaccines (Basel)10.3390/vaccines9121424 (2021).
    1. Achrekar GC, et al. Assessing COVID-19 booster hesitancy and its correlates: an early evidence from India. Vaccines. 2022;10:1048. doi: 10.3390/vaccines10071048.
    1. The Government of the Hong Kong Special Administration Region. COVID-19 Vaccination Programme. (2021).
    1. Government of Singapore. Singapore Census of Population 2020. (2021).

Source: PubMed

3
Prenumerera